SCHEMBL386142

SCHEMBL386142

[O-][n+]1cnc(-c2ccc(C(F)(F)F)cc2)cc1-c1ccccc1

nearest known ligand 0.48

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.48
KDM4E B2RXH2 1/20 0.48
CTDSP1 Q9GZU7 1/20 0.48
KIF11 P52732 1/20 0.47
TOP1 P11387 2/20 0.44
TGFBR1 P36897 1/20 0.43
BACE1 P56817 1/20 0.42
SCN2A Q99250 2/20 0.40
FAAH O00519 1/20 0.39
GLO1 Q04760 1/20 0.38
MAOB P27338 1/20 0.38
LTB4R Q15722 2/20 0.37
TP53 P04637 1/20 0.36
POLB P06746 1/20 0.36
MAPT P10636 1/20 0.36
TSHR P16473 1/20 0.36
MEN1 O00255 1/20 0.36
KMT2A Q03164 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29030628 0.86 ALDH1A1 (0.61) ALDH1A1KDM4ECTDSP1TGFBR1MEN1
SCHEMBL30566980 0.86 ALDH1A1 (0.61) ALDH1A1KDM4ECTDSP1TGFBR1MEN1
SCHEMBL386268 0.84 KDM4E (0.51) ALDH1A1KDM4ECTDSP1TOP1TGFBR1
SCHEMBL386262 0.79 ESR1 (0.36) KIF11
Hydrochloric Acid SCHEMBL386200 0.74 KDM4E (0.41) ALDH1A1KDM4ECTDSP1TOP1
SCHEMBL385322 0.74 ALDH1A1 (0.47) ALDH1A1KDM4ECTDSP1POLBMAPT
SCHEMBL4151828 0.73 KIF11 (0.63) ALDH1A1KIF11BACE1SCN2AGLO1
SCHEMBL385488 0.69 KDM4E (0.43) ALDH1A1KDM4ECTDSP1BACE1POLB
SCHEMBL386389 0.69 FYN (0.53) ALDH1A1KDM4ECTDSP1POLBMAPT
SCHEMBL385326 0.69 ALDH1A1 (0.44) ALDH1A1KDM4ECTDSP1POLBMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8101625-B2 Pyrimidinones as Casein Kinase II (CK2) modulators EXELIXIS, INC. (US) 2012-01-24 US disclosed
US-20090215803-A1 Pyrimidinones as Casein Kinase II (CK2) Modulators EXELIXIS, INC. 2009-08-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090215803-A1 Pyrimidinones as Casein Kinase II (CK2) Modulators CSNK2A1, CSNK1A1, CSNK2A2 ALDH1A1 3986/4885KDM4E 1821/4885CTDSP1 376/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.